Satoru Kawakita

Satoru Kawakita

Auto-generated profile, based on publicly available information

Satoru Kawakita

Terasaki Institute for Biomedical Innovation, Los Angeles, CA 90024, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2023 in Advanced Science
Verified
Journal Article
Open access
DSDeepak Kumar Sahel
Deepak Kumar Sahel
Lalitkumar VoraLalitkumar Vora
Lalitkumar Vora
ASAishwarya Saraswat
Aishwarya Saraswat
SSSaurabh Sharma
Saurabh Sharma
JMJasmin Monpara
Jasmin Monpara
TSThakur Raghu Raj Singh
Thakur Raghu Raj Singh
Clustered randomly interspaced short palindromic repeats (CRISPRs) and its associated endonuclease protein, i.e., Cas9, have been discovered as an immune system in bacteria and archaea; nevertheless, they are now being adopted as mainstream biotechnological/molecular scissors that can modulate ample genetic and nongenetic diseases via insertion/deletion, epigenome editing, messenger RNA editing, CRISPR interference, etc. Many Food and Drug Administration‐approved and ongoing clinical trials on CRISPR adopt ex vivo strategies, wherein the gene editing is performed ex vivo, followed by reimplantation to the patients. However, the in vivo delivery of the CRISPR components is still under preclinical surveillance. This review has summarized the nonviral nanodelivery strategies for gene editing using CRISPR/Cas9 and its recent advancements, strategic points of view, challenges, and future aspects for tissue‐specific in vivo delivery of CRISPR/Cas9 components using nanomaterials.

27 October 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SKSatoru Kawakita
Satoru Kawakita
JBJennifer L. Beaumont
Jennifer L. Beaumont
VJVadim Jucaud
Vadim Jucaud
MEMatthew J. Everly
Matthew J. Everly
Machine learning (ML) has shown its potential to improve patient care over the last decade. In organ transplantation, delayed graft function (DGF) remains a major concern in deceased donor kidney transplantation (DDKT). To this end, we harnessed ML to build personalized prognostic models to predict DGF. Registry data were obtained on adult DDKT recipients for model development (n = 55,044) and validation (n = 6176). Incidence rates of DGF were 25.1% and 26.3% for the development and validation sets, respectively. Twenty-six predictors were identified via recursive feature elimination with random forest. Five widely-used ML algorithms—logistic regression (LR), elastic net, random forest, artificial neural network (ANN), and extreme gradient boosting (XGB) were trained and compared with a baseline LR model fitted with previously identified risk factors. The new ML models, particularly ANN with the area under the receiver operating characteristic curve (ROC-AUC) of 0.732 and XGB with ROC-AUC of 0.735, exhibited superior performance to the baseline model (ROC-AUC = 0.705). This study demonstrates the use of ML as a viable strategy to enable personalized risk quantification for medical applications. If successfully implemented, our models may aid in both risk quantification for DGF prevention clinical trials and personalized clinical decision making.

13 November 2024 in Small
Verified
Journal Article
Closed access
Surjendu MaitySurjendu Maity
Surjendu Maity
TBTamanna Bhuyan
Tamanna Bhuyan
CJChristopher Jewell
Christopher Jewell
SKSatoru Kawakita
Satoru Kawakita
Saurabh SharmaSaurabh Sharma
Saurabh Sharma
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

1 February 2020 in Transplantation
Verified
Journal Article
Open access
AWAmy D. Waterman
Amy D. Waterman
JPJohn Devin Peipert
John Devin Peipert
HXHuiling Xiao
Huiling Xiao
CGChristina J. Msw Goalby
Christina J. Msw Goalby
SKSatoru Kawakita
Satoru Kawakita
KLKrista L Lentine
Krista L Lentine
Background.: Transplant education in dialysis centers can increase access to kidney transplant; however, dialysis center transplant barriers are common, and limited research identifies the most effective transplant education approaches. Methods.: We surveyed transplant educators in 1694 US dialysis centers about their transplant knowledge, use of 12 education practices, and 8 identified education barriers. Transplant wait-listing rates were calculated using US Renal Data System data. Results.: Fifty-two percent of educators orally recommended transplant to patients, 31% had in-center transplant discussions with patients, 17% distributed print educational resources, and 3% used intensive education approaches. Distribution of print education (incident rate ratio: 1.021.151.30) and using >1 intensive education practice (1.001.111.23) within dialysis centers were associated with increased wait-listing rates. Several dialysis center characteristics were associated with reduced odds of using education strategies leading to increased wait-listing. Centers with greater percentages of uninsured patients (odds ratio [OR]: 0.960.970.99), in rural locations (OR: 0.660.790.95), with for-profit ownership (OR: 0.640.770.91), and with more patients older than 65 years (OR: 0.050.110.23) had lower odds of recommending transplant, while centers with a higher patient-to-staff ratio were more likely to do so (OR: 1.011.031.04). Language barriers (OR: 0.480.640.86) and having competing work priorities (OR: 0.400.530.70) reduced the odds of distributing print education. Providers with greater transplant knowledge were more likely to use >1 intensive educational strategy (OR: 1.011.271.60) while providers who reported competing work priorities (OR: 0.510.660.84) and poor communication with transplant centers (OR: 0.580.760.98) were less likely to do so. Conclusions.: Educators should prioritize transplant education strategies shown to be associated with increasing wait-listing rates.

5 April 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Bardia YousefiBardia Yousefi
Bardia Yousefi
HAHamed Akbari
Hamed Akbari
MHMichelle Hershman
Michelle Hershman
SKSatoru Kawakita
Satoru Kawakita
Henrique FernandesHenrique Fernandes
Henrique Fernandes
Xavier MaldagueXavier Maldague
Xavier Maldague
Early diagnosis of breast cancer unequivocally improves the survival rate of patients and is crucial for disease treatment. With the current developments in infrared imaging, breast screening using dynamic thermography seems to be a great complementary method for clinical breast examination (CBE) prior to mammography. In this study, we propose a sparse deep convolutional autoencoder model named SPAER to extract low-dimensional deep thermomics to aid breast cancer diagnosis. The model receives multichannel, low-rank, approximated thermal bases as input images. SPAER provides a solution for high-dimensional deep learning features and selects the predominant basis matrix using matrix factorization techniques. The model has been evaluated using five state-of-the-art matrix factorization methods and 208 thermal breast cancer screening cases. The best accuracy was for non-negative matrix factorization (NMF)-SPAER + Clinical and NMF-SPAER for maintaining thermal heterogeneity, leading to finding symptomatic cases with accuracies of 78.2% (74.3–82.5%) and 77.7% (70.9–82.1%), respectively. SPAER showed significant robustness when tested for additive Gaussian noise cases (3–20% noise), evaluated by the signal-to-noise ratio (SNR). The results suggest high performance of SPAER for preserveing thermal heterogeneity, and it can be used as a noninvasive in vivo tool aiding CBE in the early detection of breast cancer.

29 April 2023 in Micromachines
Verified
Journal Article
Open access
PDF file
HNHuu Tuan Nguyen
Huu Tuan Nguyen
APArne Peirsman
Arne Peirsman
ZTZuzana Tirpakova
Zuzana Tirpakova
Kalpana MandalKalpana Mandal
Kalpana Mandal
FVFlorian Luc Vanlauwe
Florian Luc Vanlauwe
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini
Engineered human tissues created by three-dimensional cell culture of human cells in a hydrogel are becoming emerging model systems for cancer drug discovery and regenerative medicine. Complex functional engineered tissues can also assist in the regeneration, repair, or replacement of human tissues. However, one of the main hurdles for tissue engineering, three-dimensional cell culture, and regenerative medicine is the capability of delivering nutrients and oxygen to cells through the vasculatures. Several studies have investigated different strategies to create a functional vascular system in engineered tissues and organ-on-a-chips. Engineered vasculatures have been used for the studies of angiogenesis, vasculogenesis, as well as drug and cell transports across the endothelium. Moreover, vascular engineering allows the creation of large functional vascular conduits for regenerative medicine purposes. However, there are still many challenges in the creation of vascularized tissue constructs and their biological applications. This review will summarize the latest efforts to create vasculatures and vascularized tissues for cancer research and regenerative medicine.